SIFI

SIFI, the leading Italian ophthalmic company, has been focused on Eye Care since its foundation in 1935. Our mission is to provide ophthalmologists and their patients with a wide range of therapeutic solutions to treat the most common eye diseases, by manufacturing and marketing innovative pharmaceuticals and medical devices. SIFI features an integrated business model, from research & development to manufacturing and commercialization both in the pharmaceutical and biomedical sectors. SIFI develops its competitive advantage through a combination of internal R&D, which has led to more than 60 patents in the last few years, and a strong international network of alliances to develop new products and to market its wide product portfolio overseas. Our offering is completed with ophthalmic nutraceuticals, cosmetics and diagnostic instruments, that leverage on our specialty know-how. SIFI’s 80-years history is distinguished with the pursuit of excellence and the highest level of educational service to the ophthalmic community, most notably in Italy. Currently the SIFI Group employs around 360 people – more than 20 in R&D - and has a turnover of about € 65 million. Each year SIFI invests approximately 10% of sales in R&D. The Group is organized into two business areas – Pharma and Medtech – and its products are sold in more than 15 countries worldwide, with commercial subsidiaries in Mexico and Romania.